StemCells to initiate second clinical trial of HuCNS-SC human neural stem cells in NCL

Links shared publicly online about this topic.

1,222
total visits

StemCells to initiate second clinical trial of HuCNS-SC human neural stem cells in NCL

StemCells, Inc. announced today that it has submitted a protocol to the FDA for initiation of a second clinical trial of its proprietary HuCNS-SC human neural stem cells in neuronal ceroid lipofuscinosis, which is also often referred to as Batten disease.

View full resource at news-medical.net

Tags: Disease and Condition, Stem Cell, Clinical Trial, FDA